Detection of IgG in sera of patients with schistosomiasis japonica by developing magnetic affinity enzyme-linked immunoassay based on recombinant 14-3-3 protein

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 108, Issue 1, 2014, Pages 37-41

  Yu, Qin ^a   Yang, Hai ^b   Guan, Fei ^a   Feng, Youmei ^a   Yang, Xiangliang ^b   Zhu, Yanhong ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diagnosis; Magnetic affinity enzyme linked immunoassay; MEIA; rSj14 3 3; Schistosoma japonicum

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PRAZIQUANTEL; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN 14-3-3; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; HUMAN; MAGNETIC AFFINITY ENZYME LINKED IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PARAGONIMIASIS; SCHISTOSOMIASIS JAPONICA; SENSITIVITY AND SPECIFICITY;

DIAGNOSIS; MAGNETIC AFFINITY ENZYME-LINKED IMMUNOASSAY; MEIA; RSJ14-3-3; SCHISTOSOMA JAPONICUM;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SENSITIVITY AND SPECIFICITY;

EID: 84891322206     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt097     Document Type: Article

References (25)

1. WHO. Schistosomiasis: Progress Report 2001-2011 and Strategic Plan 2012-2020. Geneva: World Health Organization; 2013.
2. Hao Y, Zheng H, Zhu R et al. Schistosomiasis status in People's Republic of China in 2008. Chin J Schisto Control 2009;21:451-6.
3. Zhou X, Guo J, Wu X et al. Epidemiology of schistosomiasis in the People's Republic of China, 2004. Emerg Infect Dis 2007;13:1470-6.
4. Cavalcanti MG, Silva LF, Peralta RHS et al. Schistosomiasis in areas of low endemicity: a new era in diagnosis. Trends Parasitol 2013;29:75-82.
5. Coulibaly JT, N'Goran EK, Utzinger J et al. A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies. Parasit Vectors 2013;6:29-37.
6. Olsvik O, Popovic T, Skjerve E et al. Magnetic separation techniques in diagnostic microbiology. Clin Microbiol Rev 1994;7:43-54.
7. Hayat A, Barthelmebs L, Marty JL. Enzyme-linked immunosensor based on superparamagnetic nanobeads for easy and rapid detection of okadaic acid. Anal Chim Acta 2011;690:248-52.
8. Liu Z, Zhang L, Yang H et al. Magnetic microbead-based enzyme-linked immunoassay for detection of Schistosoma japonicum antibody in human serum. Anal Biochem 2010;404:127-34.
9. Luo Q, Qiao Z, Zhou Y et al. Application of signaling protein 14-3-3 and 26 kDa glutathione-S-transferase to serological diagnosis of Schistosomiasis japonica. Acta Trop 2009;112:91-6.
10. Schechtmna D, Tarrab-Hazdai R, Arnon R. The 14-3-3 protein as a vaccine candidate against schistosomiasis. Parasite Immunol 2001; 23:213-7.
11. WHO. The Control of Schistosomiasis. Geneva: World Health Organization; 1993.
12. Santana SD, Pina AS, Roque AC. Immobilization of enterokinase on magnetic supports for the cleavage of fusion proteins. J Biotechnol 2012;161:378-82.
13. Jin Y, Lu K, Zhou W et al. Comparison of recombinant proteins from Schistosoma japonicum for schistosomiasis diagnosis. Clin Vacc Immunol 2010;17:476-80.
14. Bergquist R, Johansen MV, Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol 2009;25:151-6.
15. Doenhoff MJ, Chiodini PL, Hamilton JV. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol 2004;20:35-9.
16. Gray DJ, McManus DP, Li Y et al. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 2010;10:733-6.
17. Wu W, Huang Y. Application of praziquantel in schistosomiasis japonica control strategies in China. Parasitol Res 2013;112:909-15.
18. Ross AG, Sleigh AC, Li Yet al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 2001;214:270-95.
19. Zhu Y, Hua W, Xu M et al. A novel immunodiagnostic assay to detect serum antibody response against selected soluble egg antigen fractions from Schistosoma japonicum. PLOS One 2012;7:1-6.
20. WHO. Control of Schistosomiasis. Geneva: World Health Organization; 1985.
21. Acosta LP, McManus DP, Aligui GD et al. Antigen-specific antibody isotype patterns to Schistsoma japonicum recombinant and native antigens in a defined population in Leyte, the Philippines. Am J Trop Med Hyg 2004;70:549-55.
22. Qian C,Wang J, Yu C et al. Characterization of IgG responses of rabbits to Sj14-3-3 protein after experimental infection with Schistosoma japonicum. Parasitol Res 2012;111:2209-11.
23. Angeles JM, Goto Y, Kirinoki M et al. Human antibody response to thioredoxin peroxidase-1 and tandem repeat proteins as immunodiagnostic antigen candidates for Schistosoma japonicum infection. Am J Trop Med Hyg 2011;85:674-9.
24. Tsang VC, Wilkins PP. Immunodiagnosis of schistosomiasis. Immunol Invest 1997;26:175-88.
25. Abdel-Hafeez EH, Kikuchi M,Watanabe K et al. Proteome approach for identification of schistosomiasis japonica vaccine candidate antigen. Parasitol Int 2009;58:36-44.